Brief: Evoke Pharma Inc Says Nasdaq Granted Extension
21/07/2023 14:14
July 21 (Reuters) - Evoke Pharma Inc EVOK.O :
* EVOKE PHARMA INC SAYS ON JULY 19, NASDAQ GRANTED EXTENSION
UNTIL
NOVEMBER 20, 2023 TO REGAIN COMPLIANCE. - SEC FILING
Further company coverage: EVOK.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Evoke Pharma
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Evoke Pharma Q3 sales rise 61%, expects QOL Medical acquisition to close in Q4 2025
Brief: Evoke Pharma Enters Into Definitive Agreement To Be Acquired By QOL Medical
Evoke Pharma Inc reports results for the quarter ended June 30 - Earnings Summary